7/22/26 -1%
7/22/26 -1%
YouTube8 hr 38 min
Watch on YouTube
Note: AI-generated summary based on third-party content. Not financial advice. Read more.
Quick Insights

Buy the dip on Alphabet Inc. (GOOG / GOOGL) as surging cloud revenues and massive AI infrastructure demand outweigh near-term negative free cash flow. Target a near-term price of $1,000 to $1,100 for Micron Technology (MU) as booming AI data center memory demand drives the stock higher from current levels. Utilize Super Micro Computer (SMCI) trading around $31 to $32 as a high-beta proxy to capture short-term momentum from hyperscale AI server deployments. Accumulate Arrowhead Pharmaceuticals (ARWR) in the $88 to $93 range as a strong long opportunity following recent positive clinical trial data. Treat Cerebras Systems (CBRS) as a strictly tactical trading vehicle given its extreme intraday volatility and poor profit margins near the $200–$220 range.

Detailed Analysis

Alphabet Inc. (GOOG / GOOGL)

  • Financial Results: Reported strong second-quarter 2026 results with consolidated revenues of $119.8 billion, up 24% year-over-year (23% in constant currency). Operating income increased 30% to $40.8 billion with a 34% operating margin.
  • Google Cloud Growth: Google Cloud revenues surged 82% to $24.8 billion, driven by core GCP, AI solutions, and AI infrastructure, with operating income more than tripling year-over-year to $8.8 billion (35.6% operating margin). Cloud backlog increased by over $50 billion sequentially to $514 billion.
  • Search and Advertising: Search and other revenues grew 17% to $63.3 billion, while YouTube advertising revenues increased 13% to $11.1 billion. AI-powered features like AI Overviews and AI Mode surpassed 1 billion monthly active users.
  • CapEx Increase: Updated full-year 2026 CapEx guidance to a range of $195 to $205 billion (up from $180–$190 billion), primarily due to accelerated technical infrastructure delivery to meet growing AI demand. Q2 CapEx was $44.9 billion, resulting in a negative free cash flow of $5.9 billion for the quarter.
  • Sentiment: The podcast host is broadly bullish on Google, viewing their heavy AI capital expenditures as a wise, all-in strategy rather than a cash-harvesting exercise, and suggests buying the dip.

Takeaways

  • Alphabet's aggressive capital spending on AI infrastructure highlights strong secular demand, which acts as a bellwether for the entire semiconductor and AI hardware ecosystem.
  • Investors should monitor management's commentary on 2027 CapEx acceleration and the near-term margin pressure caused by utilizing third-party capacity bridging strategies.

Micron Technology (MU)

  • Market Performance & Price Targets: Traded strongly during the session with the host noting it ran to $960, expressing a firm target of seeing Micron hit $1,000 to $1,100 very soon.
  • Sentiment: Extremely bullish. The host views Micron as a core beneficiary of memory demand driven by expanding AI data center requirements and OpenAI's rising cloud spending.

Takeaways

  • Memory chip demand remains a crucial bottleneck and profit driver in the AI infrastructure buildout.
  • Monitor memory cycle momentum and large-scale data center spending updates as primary catalysts for Micron's stock price.

Super Micro Computer (SMCI)

  • Market Performance: Experienced strong upward momentum, gaining between 16% and 31% during the reporting window, reaching around $31 to $32.
  • Sentiment: Bullish price action alongside strong results, though the host noted short-term trading volatility and attempts to fade the initial gap up.

Takeaways

  • Supermicro serves as a high-beta proxy for server rack and hardware demand tied directly to major AI infrastructure deployments by hyperscalers like OpenAI and Google.

Arrowhead Pharmaceuticals (ARWR)

  • Market Performance: Gained roughly 18% to 25% following positive clinical trial data and event reduction updates, trading around the $88 to $93 range.
  • Sentiment: Strongly positive clinical and fundamental view, though trading action became directionless and flat following the initial gap up.

Takeaways

  • Biotech investments require patience through clinical data readouts and regulatory updates, independent of broader macroeconomic tech trends.
  • Highlighted as a potential long opportunity following positive clinical data releases.

Cerebras Systems (CBRS)

  • Market Performance: Experienced extreme intraday volatility, spiking up on OpenAI spending news before crashing back down in a sharp wave of red candles, dropping toward the $200–$220 range.
  • Sentiment: Highly speculative and volatile ("money flow driven"). The host noted concerns regarding poor profit margins, despite benefiting indirectly from overall AI chip demand and partnerships with OpenAI models.

Takeaways

  • High volatility makes Cerebras a tactical trading vehicle rather than a stable long-term investment.
  • Investors should closely evaluate chipmaker margins versus pure top-line revenue growth when assessing AI hardware startups.

ServiceNow (NOW)

  • Financial Results: Reported strong earnings beating high-end guidance, with subscription revenues at $3.87 billion (total revenues $3.99 billion) and consistent 20% growth.
  • Sentiment: Bullish. The host praised CEO Bill McDermott as a "hero" and a "legend," dismissing fears that automated AI coding tools (like Claude) would disrupt ServiceNow's enterprise platform model.

Takeaways

  • Enterprise software providers with entrenched workflows continue to demonstrate robust growth and pricing power despite broader software-pocalypse (saspocalypse) narratives.
Ask about this postAnswers are grounded in this post's content.
Video Description
let's get this $
About Martin Shkreli
Martin Shkreli

Martin Shkreli

By @realmartinshkreli

Investing, music, science, math, technology, programming, medicine and more!